Journal Guide

Brain Tumor Pathology is the official journal of the Japan Society of Brain Tumor Pathology. This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal has been published since 1983 and has been recognized worldwide as a unique journal of high quality. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics. The latter are papers recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions should be aimed at promoting international scientific collaboration.

To disseminate original scientific research that contributes to the advancement of human movement sciences with emphasis on kinanthropometry in both its morphological and functional aspects as well as the conditioning factors of physical performance.

Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.

Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a `market place' for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.

Oncology is undoubtedly the most rapidly growing subspecialty in the field of medicine, and breast cancer is one of the most serious problems of oncology. It is the leading cause of death of women in many countries and is truly a multidisciplinary problem without geographic restrictions. Yet this very multidisciplinary aspect accounts for breast cancer literature appearing in any of the dozens of existing medical journals. None of these jou

Briefings in Bioinformatics is an international forum for researchers and educators in the life sciences. The journal publishes reviews for the users of databases and analytical tools of contemporary genetics and molecular biology and is unique in providing practical help and guidance to the non-specialist. Papers range in scope and depth, from the introductory level to specific details of protocols and analyses encompassing bacterial, plant, animal and human data.Detailed subject areas covered by the journal include: DNA sequencing, expression profiling, alignment methods, gene expression studies, protein profiles and HMMs, metabolic and signalling pathways, structure and function prediction, mapping and microarrays.

Briefings in Functional Genomics is an international forum reviewing the use, development and exploitation of functional genomic approaches in all areas of biological research. The journal provides a centralised resource for researchers in the field of functional genomics as well as guidance to scientists new to the area. Subjects covered by BFG include but are not restricted to: the identification and functional characterisation of coding and non-coding features in genomes, microarray technologies, gene expression profiling, next generation sequencing, pharmacogenomics, phenomics, SNP technologies, transgenic systems, mutation screens and genotyping. Articles range in scope and depth from the introductory level to specific details of protocols and analyses, encompassing bacterial, fungal, plant, animal and human data.

poisoning and infection control biomedical scientists are the foundation of modern healthcare. Biomedical scientists work in partnership with doctors, nurses and other healthcare professionals to perform many different roles in NHS laboratories. Without biomedical scientists the diagnosis of disease, the evaluation of the effectiveness of treatment, and research into the causes and cures of disease would not be possible.Doctors treat their patients based on results of the vital tests and investigations that diagnose often serious and life threatening illnesses such as cancer, AIDS or diabetes. Without biomedical scientists departments such as Accident & Emergency and operating theatres could not properly function. The many roles of support by biomedical scientists for A & E and theatre surgery includes tests for emergency blood transfusions and blood grouping as well as tests on samples from patients who have overdosed on unknown substances, or may have leukaemia or are suspected of having a heart attack.The work of a biomedical scientist must be accurate and efficient because patients' lives may depend on their skills. They are continually increasing their knowledge as laboratory techniques develop and research transforms the cutting edge of science and medicine. Scientists learn to work with computers, sophisticated automated equipment, microscopes and other hi-tech laboratory equipment. They employ a wide range of complex modern techniques to perform their.

Cancer is a complex problem. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most biological disciplines, chemistry, pharmaceutical and physical sciences. British Journal of Cancer (BJC) exists to serve the needs of this diverse community, providing a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients. BJC works with a distinguished team of international experts to ensure the highest standards of selection and review. All relevant papers are carefully considered. Once accepted, papers are published rapidly in print and online.Full research papers and short communications are published under five broad headings: * clinical studies * translational therapeutics * molecular diagnostics * genetics and genomics * epidemiologyBJC regularly invites minireviews on topics of current interest from international authorities. Some longer reviews, and book reviews are published, usually by editor's invitation. Editorials and letters to the editor on matters arising from published papers are also published at the editor's discretion.BJC is owned by Cancer Research UK, the world's leading independent charity dedicated to cancer research. Cancer Research UK carries out scientific research to find news ways of preventing, diagnosing and treating cancer; ensuring findings are used to benefit the lives of cancer patients.BJC reflects this purpose. It was founded more than sixty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. Broad coverage, its editorial independence and consistent high standards have made British Journal of Cancer one of the world's premier general cancer journals.

From Biology to Clinical practice : a modern approach of oncologyWhile giving space to review articles and paying more attention to biological aspects, the Bulletin du Cancer maintains a highly scientific clinical and therapeutic approach.The Bulletin du Cancer is one of the best scientific publications in the French language in the realm of cancerology. It is listed in the leading international databases.The Bulletin du Cancer is the official organ of the French Cancer Society.The online version of Bulletin du Cancer is available. All articles published since 1997 can now be accessed online. Recent articles are available by pay per view or by subscription while older ones have free access.

Bulletin of Experimental Biology and Medicine is a translation of two Russian journals: Byulleten Eksperimental'noi Biologii i Meditsiny and Kletochnye Tekhnologii v Biologii i Meditsine. Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, and other topics. Recently introduced sections of the journal, entitled Biogerontology and Human Ecology cover novel trends in science. World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal called Cell Technologies in Biology and Medicine. This publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors

The Bulletin of Mathematical Biology is devoted to research at the junction of computational, theoretical and experimental biology. Articles offer a combination of theory and experiment, documenting theoretical advances with clear exposition of how they further biological understanding. Its aim is to be of major interest to theorists and experimental biologists alike.The Bulletin of mathematical biology also invites submissions of review articles which offer an in-depth treatment of an emerging research area, or a significant recent development, in the general area of computational, theoretical and mathematical biology. Those interested in writing such a review article should contact James Sneyd at sneyd@math.auckland.ac.nz This is the official journal of the Society for Mathematical Biology.

CBE-LSE publishes peer-reviewed articles on life science education at the K 12, undergraduate, and graduate levels. The ASCB believes that learning in biology encompasses diverse fields, including math, chemistry, physics, engineering, computer science, and the interdisciplinary intersections of biology with these fields. Within biology, CBE-LSE focuses on how students are introduced to the study of life sciences, as well as approaches in cell biology, developmental biology, neuroscience, biochemistry, molecular biology, genetics, genomics, bioinformatics, and proteomics. CBE-LSE is written by and to serve professionals engaged in biology teaching in all environments, including faculty at large research universities who teach but do not view teaching as their primary mission, as well as those whose teaching is the major focus of their careers, in primarily undergraduate institutions, museums and outreach programs, junior and community colleges, and K 12 schools.

Calcified Tissue International was founded in 1967 under the name Calcified Tissue Research. Vols. 1-19 were edited by B.E.C. Nordin, F.G.E. Pautard, D. B. Scott, B.A. Friedman; Vols. 20-22 by B.E.C. Nordin, F.G.E. Pautard, B.A. Friedman, L. Klein; Vols. 23-24 by W.D. Armstrong. Beginning with Vol. 27 in 1979, the journal was renamed Calcified Tissue International and was edited by L. V. Avioli until 1999. Vols. 66-75, were then co-edited by Drs. R. Civitelli, K.A. Hruska, and S. Ralston. Vols. 76-92, were co-edited by Drs. R. Civitelli and S.H. Ralston. Since Vol. 93 the journal, which was renamed Calcified Tissue International and Musculoskeletal Research has been co-edited by Drs. S.H. Ralston and R. Rizzoli.The Journal serves as a forum to explore the biochemical, biophysical, molecular, and genetic determinants of the structure, function, and metabolism of bone, and other musculoskeletal  tissues in living organisms. It publishes preclinical and translational research on these topics as well as clinical